Asahi Life Asset Management Co., Ltd. Organon & Co. Transaction History

Asahi Life Asset Management Co., Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$16.59 - $23.77 $3,915 - $5,609	236 Added 1.74%	13,815 $239,000
Q2 2023 Jul 21, 2023	SELL	$19.27 - $24.63 $799,088 - $1.02 Million	-41,468 Reduced 75.33%	13,579 $282,000
Q1 2023 May 01, 2023	SELL	$21.42 - $32.08 $51,707 - $77,441	-2,414 Reduced 4.2%	55,047 $1.29 Million
Q4 2022 Feb 10, 2023	SELL	$23.31 - $28.61 $52,027 - $63,857	-2,232 Reduced 3.74%	57,461 $1.61 Million
Q3 2022 Nov 07, 2022	SELL	$23.4 - $34.25 $512,998 - $750,862	-21,923 Reduced 26.86%	59,693 $1.4 Million
Q2 2022 Aug 02, 2022	SELL	$31.66 - $38.9 $223,108 - $274,128	-7,047 Reduced 7.95%	81,616 $2.76 Million
Q1 2022 May 11, 2022	BUY	$30.45 - $39.36 $951,653 - $1.23 Million	31,253 Added 54.44%	88,663 $3.1 Million
Q4 2021 Feb 02, 2022	BUY	$28.67 - $37.13 $1.65 Million - $2.13 Million	57,410 New	57,410 $1.79 Million
Q3 2021 Oct 29, 2021	SELL	$28.63 - $35.64 $15,918 - $19,815	-556 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$28.45 - $38.0 $15,818 - $21,128	556 New	556 $17,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Asahi Life Asset Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asahi Life Asset Management Co., Ltd. with notifications on news.